The role of biomarkers in low respiratory tract infections

被引:12
|
作者
Blasi, Francesco [1 ]
Bocchino, Marialuisa [2 ]
Di Marco, Fabiano [3 ]
Richeldi, Luca [4 ]
Aliberti, Stefano [5 ]
机构
[1] Univ Milan, Dipartimento Toracopolmonare & Cardiocircolatorio, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Milan, Italy
[2] Univ Naples Federico II, Dipartimento Med Clin & Sperimentale, Sez Malattie Apparato Resp, Naples, Italy
[3] Univ Milan, Resp Med Sect, Dipartimento Toracopolmonare & Cardiocircolatorio, Osped San Paolo, Milan, Italy
[4] Univ Modena & Reggio Emilia, Policlin Hosp, Ctr Rare Lung Dis, I-41100 Modena, Italy
[5] Univ Milano Bicocca, Dipartimento Med Clin & Prevenz, Clin Pneumol, AO San Gerardo, Monza, Italy
关键词
Biomarker; Procalcitonin; C-reactive protein; Proadrenomedullin; Pneumonia; COPD; C-REACTIVE PROTEIN; COMMUNITY-ACQUIRED PNEUMONIA; VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE UNITS; ANTIBIOTIC-THERAPY; PROCALCITONIN-GUIDANCE; MYELOID CELLS-1; NATRIURETIC PEPTIDE; ACUTE EXACERBATION; PREDICT SEVERITY;
D O I
10.1016/j.ejim.2012.05.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Low respiratory tract infections (LRTI) represent the leading infectious cause of death worldwide and account for substantial use of healthcare resources. Physicians must adopt practices focused on improving outcomes and serum biomarker can help them in the management of patients with LRTI. Several studies have been carried out or are currently ongoing to evaluate the role of various biomarkers for the differential diagnosis, definition of prognosis, treatment and duration of antibiotic therapy in respiratory infections. The objective of this position paper of the Italian Society of Respiratory Diseases (SIMER) is to provide evidence-based recommendations for the use of biomarkers in routine clinical practice in the management of adult patients with LRTI. These guidelines capture the use of biomarkers both outside and inside the hospital, focused on community-acquired pneumonia, acute exacerbations of chronic obstructive pulmonary disease, hospitalacquired and ventilator-acquired pneumonia. (C) 2012 European Federation of Internal Medicine. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:429 / 435
页数:7
相关论文
共 50 条
  • [31] Prognostic impact of plasma lipids in patients with lower respiratory tract infections - an observational study
    Gruher, Maja
    Christ-Crain, Mirjam
    Stolz, Daiana
    Keller, Ulrich
    Mueller, Christian
    Bingisser, Roland
    Tamm, Michael
    Mueller, Beat
    Schuetz, Philipp
    SWISS MEDICAL WEEKLY, 2009, 139 (11-12) : 166 - 172
  • [32] Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic
    Chalmers, James D.
    Al-Khairalla, Mudher
    Short, Philip M.
    Fardon, Tom C.
    Winter, John H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (04) : 608 - 618
  • [33] Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections - hope for hype?
    Schuetz, Philipp
    Christ-Crain, Mirjam
    Mueller, Beat
    SWISS MEDICAL WEEKLY, 2009, 139 (23-24) : 318 - 326
  • [34] Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
    Schuetz, Philipp
    Wirz, Yannick
    Sager, Ramon
    Christ-Crain, Mirjam
    Stolz, Daiana
    Tammy, Michael
    Bouadma, Lila
    Luyt, Charles E.
    Wolff, Michel
    Chastre, Jean
    Tubach, Florence
    Kristoffersen, Kristina B.
    Burkhardt, Olaf
    Welte, Tobias
    Schroeder, Stefan
    Nobre, Vandack
    Wei, Long
    Bucher, Heiner C.
    Bhatnagar, Neera
    Annane, Djillali
    Reinhart, Konrad
    Branche, Angela
    Damas, Pierre
    Nijsten, Maarten
    de Lange, Dylan W.
    Deliberato, Rodrigo O.
    Lima, Stella S. S.
    Maravic-Stojkovic, Vera
    Verduri, Alessia
    Cao, Bin
    Shehabi, Yahya
    Beishuizen, Albertus
    Jensen, Jens-Ulrik S.
    Corti, Caspar
    Van Oers, Jos A.
    Falsey, Ann R.
    de Jong, Evelien
    Oliveira, Carolina F.
    Beghe, Bianca
    Briel, Matthias
    Mueller, Beat
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (10):
  • [35] Guidelines for the management of adult lower respiratory tract infections - Summary
    Woodhead, M.
    Blasi, F.
    Ewig, S.
    Garau, J.
    Huchon, G.
    Ieven, M.
    Ortqvist, A.
    Schaberg, T.
    Torres, A.
    van der Heijden, G.
    Read, R.
    Verheij, T. J. M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 : 1 - 24
  • [36] Reducing uncertainty in managing respiratory tract infections in primary care
    Stanton, Naomi
    Francis, Nick A.
    Butler, Chris C.
    BRITISH JOURNAL OF GENERAL PRACTICE, 2010, 60 (581) : e466 - e475
  • [37] Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis
    Polzin, A
    Pletz, M
    Erbes, R
    Raffenberg, M
    Mauch, H
    Wagner, S
    Arndt, G
    Lode, H
    EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (06) : 939 - 943
  • [38] Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
    Schuetz, Philipp
    Mueller, Beat
    Christ-Crain, Mirjam
    Stolz, Daiana
    Tamm, Michael
    Bouadma, Lila
    Luyt, Charles E.
    Wolff, Michel
    Chastre, Jean
    Tubach, Florence
    Kristoffersen, Kristina B.
    Burkhardt, Olaf
    Welte, Tobias
    Schroeder, Stefan
    Nobre, Vandack
    Wei, Long
    Bhatnagar, Neera
    Bucher, Heiner C.
    Briel, Matthias
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):
  • [39] Personalized medicine of patients with respiratory infections through the measurement of specific blood biomarkers: fact or fiction?
    Schuetz, Philipp
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (08) : 605 - 607
  • [40] Combined use of biomarkers for distinguishing between bacterial and viral etiologies in pediatric lower respiratory tract infections
    Zhu, Guoji
    Zhu, Jie
    Song, Lei
    Cai, Wenzhi
    Wang, Jian
    INFECTIOUS DISEASES, 2015, 47 (05) : 289 - 293